On the Common Journey of Neural Cells through Ischemic Brain Injury and Alzheimer's Disease

Int J Mol Sci. 2021 Sep 7;22(18):9689. doi: 10.3390/ijms22189689.

Abstract

Ischemic brain injury and Alzheimer's disease (AD) both lead to cell death in the central nervous system (CNS) and thus negatively affect particularly the elderly population. Due to the lack of a definitive cure for brain ischemia and AD, it is advisable to carefully study, compare, and contrast the mechanisms that trigger, and are involved in, both neuropathologies. A deeper understanding of these mechanisms may help ameliorate, or even prevent, the destructive effects of neurodegenerative disorders. In this review, we deal with ischemic damage and AD, with the main emphasis on the common properties of these CNS disorders. Importantly, we discuss the Wnt signaling pathway as a significant factor in the cell fate determination and cell survival in the diseased adult CNS. Finally, we summarize the interesting findings that may improve or complement the current sparse and insufficient treatments for brain ischemia and AD, and we delineate prospective directions in regenerative medicine.

Keywords: Alzheimer’s disease; Wnt signaling; amyloid beta; central nervous system; dementia; ischemic brain injury; neurodegeneration; stroke.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / etiology*
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Biomarkers
  • Brain Injuries / etiology
  • Brain Injuries / metabolism
  • Brain Injuries / pathology
  • Brain Ischemia / etiology*
  • Brain Ischemia / metabolism*
  • Brain Ischemia / pathology
  • Disease Susceptibility*
  • Humans
  • Nerve Degeneration
  • Neurons / metabolism*
  • Wnt Signaling Pathway

Substances

  • Amyloid beta-Peptides
  • Biomarkers